Are Drug Firms Providing Shareholder Value?

19 May 1996

The global pharmaceutical industry has experienced many changes in recent years in its attempts to address health care reform and demands for cost containment, be innovative and competitive, and improve market share. Whilst addressing these issues, do drug companies still provide shareholder value?

Speakers at broker Lehman Brothers eighth annual European health care conference attempted to address this as the main theme of the meeting earlier this month. Two firms that have been active in the consolidation of the drug industry are Pharmacia & Upjohn and Rhone-Poulenc Rorer. Both are viewed as outperformers in the industry.

The latter is aiming to build shareholder value by implementing a growth strategy, which began with the merger of Rhone-Poulenc's health care business with Rorer, and was boosted recently by the acquisition of Fisons.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight